Global Virus Like Particles Market Status and Outlook 2018-2025

August 2018 | 141 pages | ID: GB4FD2A0EA5EN
99Strategy

Abstracts

REPORT SNAPSHOT

Key Content of Chapters (Including and can be customized, report is a semifinished version, and it takes 48-72 hours to upgrade)

Part 1:
Terminology Definition, Industry Chain,Industry Dynamics & Regulations and Global Market Overview
Part 2:
Upstream (Raw Materials / Components) & Manufacturing (Procurement Methods & Channels and Cost), Major Regional Production Overview and Trade Flow
Part 3:
Product Segment Overview and Market Status
Part 4:
Application / End-User Segment Overview and Market Status
Part 5:
Region Segment Overview and Market Status
Part 6:
Product & Application Segment Production & Demand by Region
Part 7:
Market Forecast by Product, Application & Region
Part 8:
Company information, Products & Services and Business Operation (Sales, Cost, Margin etc.)
Part 9:
Market Competition and Environment for New Entrants
Part 10:
Conclusion

Market Segment as follows:

Key Companies

• GlaxoSmithKline
• Merck
• Novavax
• Takeda
• Medicago
• MedImmune
• TechnoVax
• Agilvax
• Allergy Therapeutics
• Serum Institute of India
• GeoVax Labs
• Cytos Biotechnology
• ANGANY Genetics
• CPL Biologicals
• Xiamen Innovax Biotech

Market by Type

• Adeno-Associated Virus
• HIV
• Hepatitis B Virus
• Hepatitis C Virus
• Others

Market by Application

• Vaccines
• Mycoviruses
• Virus Research
• Therapeutic and Imaging Agents
• Others

Contents

PART 1 INDUSTRY OVERVIEW (200 USD)

1.1 Virus Like Particles Industry
  1.1.1 Market Development
  1.1.2 Terminology Definition in the Report
    1.1.2.1 Production
    1.1.2.2 Demand
    1.1.2.3 Sales Revenue
    1.1.2.4 Ex-factory Price & Sales Price
    1.1.2.5 Cost
    1.1.2.6 Gross Margin
1.2 Products & Services Scope
1.3 Industry Chain
1.4 Industry Dynamics & Regulations
1.5 Global Market Overview

PART 2 UPSTREAM & PRODUCTION (200 USD)

2.1 Raw Materials / Components
2.2 Procurement Methods & Channels
2.3 Cost Structure & Manufacturing
2.4 Industry Capacity
2.5 Production Distribution by Geography
  2.5.1 Production in Major Regions / Countries
  2.5.2 Trade Flow Overview

PART 3 PRODUCT SEGMENT (400 USD)

3.1 Introduction by Type
  3.1.1 Adeno-Associated Virus
  3.1.2 HIV
  3.1.3 Hepatitis B Virus
  3.1.4 Hepatitis C Virus
  3.1.5 Others
3.2 Market Status

PART 4 APPLICATION / END-USER SEGMENT (400 USD)

4.1 Introduction by Application
  4.1.1 Vaccines
  4.1.2 Mycoviruses
  4.1.3 Virus Research
  4.1.4 Therapeutic and Imaging Agents
  4.1.5 Others
4.2 Market Status

PART 5 REGIONAL MARKET (600 USD)

5.1 Market Overview
5.2 by Region
  5.2.1 North America
    5.2.1.1 United States Market Size and Growth (2015-2018E)
    5.2.1.2 Canada Market Size and Growth (2015-2018E)
    5.2.1.3 Mexico Market Size and Growth (2015-2018E)
  5.2.2 Europe
    5.2.2.1 Germany Market Size and Growth (2015-2018E)
    5.2.2.2 UK Market Size and Growth (2015-2018E)
    5.2.2.3 France Market Size and Growth (2015-2018E)
    5.2.2.4 Italy Market Size and Growth (2015-2018E)
    5.2.2.5 Spain Market Size and Growth (2015-2018E)
    5.2.2.6 Netherlands Market Size and Growth (2015-2018E)
    5.2.2.7 Poland Market Size and Growth (2015-2018E)
    5.2.2.8 Belgium Market Size and Growth (2015-2018E)
    5.2.2.9 Sweden Market Size and Growth (2015-2018E)
    5.2.2.10 Austria Market Size and Growth (2015-2018E)
    5.2.2.11 Denmark Market Size and Growth (2015-2018E)
    5.2.2.12 Switzerland Market Size and Growth (2015-2018E)
    5.2.2.13 Russia Market Size and Growth (2015-2018E)
  5.2.3 Asia-Pacific
    5.2.3.1 China Market Size and Growth (2015-2018E)
    5.2.3.2 India Market Size and Growth (2015-2018E)
    5.2.3.3 Japan Market Size and Growth (2015-2018E)
    5.2.3.4 Korea Market Size and Growth (2015-2018E)
    5.2.3.5 Australia Market Size and Growth (2015-2018E)
    5.2.3.6 Indonesia Market Size and Growth (2015-2018E)
    5.2.3.7 Thailand Market Size and Growth (2015-2018E)
    5.2.3.8 Malaysia Market Size and Growth (2015-2018E)
    5.2.3.9 Singapore Market Size and Growth (2015-2018E)
    5.2.3.10 Philippines Market Size and Growth (2015-2018E)
  5.2.4 South America
    5.2.4.1 Brazil Market Size and Growth (2015-2018E)
    5.2.4.2 Argentina Market Size and Growth (2015-2018E)
    5.2.4.3 Columbia Market Size and Growth (2015-2018E)
    5.2.4.4 Chile Market Size and Growth (2015-2018E)
    5.2.4.5 Peru Market Size and Growth (2015-2018E)
    5.2.4.6 Puerto Rico Market Size and Growth (2015-2018E)
    5.2.4.7 Ecuador Market Size and Growth (2015-2018E)
  5.2.5 Middle East
    5.2.5.1 Saudi Arabia Market Size and Growth (2015-2018E)
    5.2.5.2 Iran Market Size and Growth (2015-2018E)
    5.2.5.3 UAE Market Size and Growth (2015-2018E)
    5.2.5.4 Oman Market Size and Growth (2015-2018E)
    5.2.5.5 Kuwait Market Size and Growth (2015-2018E)
    5.2.5.6 Iraq Market Size and Growth (2015-2018E)
    5.2.5.7 Turkey Market Size and Growth (2015-2018E)
  5.2.6 Africa
    5.2.6.1 South Africa Market Size and Growth (2015-2018E)
    5.2.6.2 Egypt Market Size and Growth (2015-2018E)
    5.2.6.3 Nigeria Market Size and Growth (2015-2018E)
    5.2.6.4 Algeria Market Size and Growth (2015-2018E)
    5.2.6.5 Angola Market Size and Growth (2015-2018E)
    5.2.6.6 Morocco Market Size and Growth (2015-2018E)
    5.2.6.7 Sudan Market Size and Growth (2015-2018E)

PART 6 MARKET SUBDIVISION (800 USD)

6.1 Regional Production
  6.1.1 Production by Type
    6.1.1.1 Adeno-Associated Virus Production by Region
    6.1.1.2 HIV Production by Region
    6.1.1.3 Hepatitis B Virus Production by Region
    6.1.1.4 Hepatitis C Virus Production by Region
    6.1.1.5 Others Production by Region
  6.1.2 Production by Application
    6.1.2.1 Vaccines Production by Region
    6.1.2.2 Mycoviruses Production by Region
    6.1.2.3 Virus Research Production by Region
    6.1.2.4 Therapeutic and Imaging Agents Production by Region
    6.1.2.5 Others Production by Region
6.2 Regional Demand
  6.2.1 Demand by Type
    6.2.1.1 Adeno-Associated Virus Demand by Region
    6.2.1.2 HIV Demand by Region
    6.2.1.3 Hepatitis B Virus Demand by Region
    6.2.1.4 Hepatitis C Virus Demand by Region
    6.2.1.5 Others Demand by Region
  6.2.2 Demand by Application
    6.2.2.1 Vaccines Demand by Region
    6.2.2.2 Mycoviruses Demand by Region
    6.2.2.3 Virus Research Demand by Region
    6.2.2.4 Therapeutic and Imaging Agents Demand by Region
    6.2.2.5 Others Demand by Region

PART 7 MARKET FORECAST (200 USD)

7.1 Global Forecast
7.2 Forecast by Type
7.3 Forecast by Application
7.4 Forecast by Region

PART 8 KEY COMPANIES LIST (600 USD)

8.1 GlaxoSmithKline
  8.1.2 Company Information
  8.1.2 Products & Services
  8.1.3 Business Operation
8.2 Merck
  8.2.1 Company Information
  8.2.2 Products & Services
  8.2.3 Business Operation
8.3 Novavax
  8.3.1 Company Information
  8.3.2 Products & Services
  8.3.3 Business Operation
8.4 Takeda
  8.4.1 Company Information
  8.4.2 Products & Services
  8.4.3 Business Operation
8.5 Medicago
  8.5.1 Company Information
  8.5.2 Products & Services
  8.5.3 Business Operation
8.6 MedImmune
  8.6.1 Company Information
  8.6.2 Products & Services
  8.6.3 Business Operation
8.7 TechnoVax
  8.7.1 Company Information
  8.7.2 Products & Services
  8.7.3 Business Operation
8.8 Agilvax
  8.8.1 Company Information
  8.8.2 Products & Services
  8.8.3 Business Operation
8.9 Allergy Therapeutics
  8.9.1 Company Information
  8.9.2 Products & Services
  8.9.3 Business Operation
8.10 Serum Institute of India
  8.10.1 Company Information
  8.10.2 Products & Services
  8.10.3 Business Operation
8.11 GeoVax Labs
8.12 Cytos Biotechnology
8.13 ANGANY Genetics
8.14 CPL Biologicals
8.15 Xiamen Innovax Biotech

PART 9 COMPANY COMPETITION (500 USD)

9.1 Market by Company
9.2 Price & Gross Margin
9.3 Competitive Environment for New Entrants
  9.3.1 Michael Porter's Five Forces Model
  9.3.2 SWOT

PART 10 RESEARCH CONCLUSION (100 USD)

List Of Tables

LIST OF TABLES

Table Virus Like Particles Industry Dynamics & Regulations List
Table Global Virus Like Particles Sales Revenue, Cost and Margin, 2015-2018E
Table Global Virus Like Particles Market Status by Type 2015-2018E, in USD Million
Table Global Virus Like Particles Market Status by Application 2015-2018E, in USD Million
Table Global Virus Like Particles Market Status by Application 2015-2018E, in Volume
Table Global Virus Like Particles Market by Region 2015-2018E, in USD Million
Table Global Virus Like Particles Market Share by Region in 2018, in USD Million
Table Global Virus Like Particles Market by Region 2015-2018E, in Volume
Table Global Virus Like Particles Market Share by Region in 2018, in Volume
Table Adeno-Associated Virus Production Value by Region 2015-2018E, in USD Million
Table Adeno-Associated Virus Production Volume by Region 2015-2018E, in Volume
Table HIV Production Value by Region 2015-2018E, in USD Million
Table HIV Production Volume by Region 2015-2018E, in Volume
Table Hepatitis B Virus Production Value by Region 2015-2018E, in USD Million
Table Hepatitis B Virus Production Volume by Region 2015-2018E, in Volume
Table Hepatitis C Virus Production Value by Region 2015-2018E, in USD Million
Table Hepatitis C Virus Production Volume by Region 2015-2018E, in Volume
Table Others Production Value by Region 2015-2018E, in USD Million
Table Others Production Volume by Region 2015-2018E, in Volume
Table Vaccines Production Value by Region 2015-2018E, in USD Million
Table Vaccines Production Volume by Region 2015-2018E, in Volume
Table Mycoviruses Production Value by Region 2015-2018E, in USD Million
Table Mycoviruses Production Volume by Region 2015-2018E, in Volume
Table Virus Research Production Value by Region 2015-2018E, in USD Million
Table Virus Research Production Volume by Region 2015-2018E, in Volume
Table Therapeutic and Imaging Agents Production Value by Region 2015-2018E, in USD Million
Table Therapeutic and Imaging Agents Production Volume by Region 2015-2018E, in Volume
Table Others Production Value by Region 2015-2018E, in USD Million
Table Others Production Volume by Region 2015-2018E, in Volume
Table Adeno-Associated Virus Market Size by Region 2015-2018E, in USD Million
Table Adeno-Associated Virus Market Size by Region 2015-2018E, in Volume
Table HIV Market Size by Region 2015-2018E, in USD Million
Table HIV Market Size by Region 2015-2018E, in Volume
Table Hepatitis B Virus Market Size by Region 2015-2018E, in USD Million
Table Hepatitis B Virus Market Size by Region 2015-2018E, in Volume
Table Hepatitis C Virus Market Size by Region 2015-2018E, in USD Million
Table Hepatitis C Virus Market Size by Region 2015-2018E, in Volume
Table Others Market Size by Region 2015-2018E, in USD Million
Table Others Market Size by Region 2015-2018E, in Volume
Table Vaccines Market Size by Region 2015-2018E, in USD Million
Table Vaccines Market Size by Region 2015-2018E, in Volume
Table Mycoviruses Market Size by Region 2015-2018E, in USD Million
Table Mycoviruses Market Size by Region 2015-2018E, in Volume
Table Virus Research Market Size by Region 2015-2018E, in USD Million
Table Virus Research Market Size by Region 2015-2018E, in Volume
Table Therapeutic and Imaging Agents Market Size by Region 2015-2018E, in USD Million
Table Therapeutic and Imaging Agents Market Size by Region 2015-2018E, in Volume
Table Others Market Size by Region 2015-2018E, in USD Million
Table Others Market Size by Region 2015-2018E, in Volume
Table GlobalVirus Like Particles Forecast by Type 2019F-2025F, in USD Million
Table Virus Like Particles Forecast by Type 2019F-2025F, in Volume
Table Virus Like Particles Market Forecast by Application / End-User 2019F-2025F, in USD Million
Table Virus Like Particles Market Forecast by Application / End-User 2019F-2025F, in Volume
Table Virus Like Particles Market Forecast by Region 2019F-2025F, in USD Million
Table Virus Like Particles Market Forecast by Region 2019F-2025F, in Volume
Table GlaxoSmithKline Information
Table Virus Like Particles Sales, Cost, Margin of GlaxoSmithKline
Table Merck Information
Table Virus Like Particles Sales, Cost, Margin of Merck
Table Novavax Information
Table Virus Like Particles Sales, Cost, Margin of Novavax
Table Takeda Information
Table Virus Like Particles Sales, Cost, Margin of Takeda
Table Medicago Information
Table Virus Like Particles Sales, Cost, Margin of Medicago
Table MedImmune Information
Table Virus Like Particles Sales, Cost, Margin of MedImmune
Table TechnoVax Information
Table Virus Like Particles Sales, Cost, Margin of TechnoVax
Table Agilvax Information
Table Virus Like Particles Sales, Cost, Margin of Agilvax
Table Allergy Therapeutics Information
Table Virus Like Particles Sales, Cost, Margin of Allergy Therapeutics
Table Serum Institute of India Information
Table Virus Like Particles Sales, Cost, Margin of Serum Institute of India
Table GeoVax Labs Information
Table Virus Like Particles Sales, Cost, Margin of GeoVax Labs
Table Cytos Biotechnology Information
Table Virus Like Particles Sales, Cost, Margin of Cytos Biotechnology
Table ANGANY Genetics Information
Table Virus Like Particles Sales, Cost, Margin of ANGANY Genetics
Table CPL Biologicals Information
Table Virus Like Particles Sales, Cost, Margin of CPL Biologicals
Table Xiamen Innovax Biotech Information
Table Virus Like Particles Sales, Cost, Margin of Xiamen Innovax Biotech
Table Global Virus Like Particles Sales Revenue by Company 2015-2017, in USD Million
Table Global Virus Like Particles Sales Volume by Company 2015-2017, in Volume
Table Global Virus Like Particles Sales Volume by Company in 2018, in Volume

List Of Figures

LIST OF FIGURES

Figure Virus Like Particles Picture
Figure Virus Like Particles Industry Chain Diagram
Figure Global Virus Like Particles Sales Revenue 2015-2018E, in USD Million
Figure Global Virus Like Particles Sales Volume 2015-2018E, in Volume
Figure Global Virus Like Particles Market Status by Type 2015-2018E, in Volume
Figure North America Virus Like Particles Market Size and Growth 2015-2018E, in USD Million
Figure North America Virus Like Particles Market Size and Growth 2015-2018E, in Volume
Figure Europe Virus Like Particles Market Size and Growth 2015-2018E, in USD Million
Figure Europe Virus Like Particles Market Size and Growth 2015-2018E, in Volume
Figure Asia-Pacific Virus Like Particles Market Size and Growth 2015-2018E, in USD Million
Figure Asia-Pacific Virus Like Particles Market Size and Growth 2015-2018E, in Volume
Figure South America Virus Like Particles Market Size and Growth 2015-2018E, in USD Million
Figure South America Virus Like Particles Market Size and Growth 2015-2018E, in Volume
Figure Middle East Virus Like Particles Market Size and Growth 2015-2018E, in USD Million
Figure Middle East Virus Like Particles Market Size and Growth 2015-2018E, in Volume
Figure Africa Virus Like Particles Market Size and Growth 2015-2018E, in USD Million
Figure Africa Virus Like Particles Market Size and Growth 2015-2018E, in Volume
Figure Global Virus Like Particles Sales Revenue Forecast 2019F-2025F, in USD Million
Figure Global Virus Like Particles Sales Volume Forecast 2019F-2025F, in Volume
Figure Global Virus Like Particles Sales Price Forecast 2019F-2025F
Figure Global Virus Like Particles Gross Margin Forecast 2019F-2025F
Figure Global Virus Like Particles Sales Revenue by Company in 2018, in USD Million
Figure Global Virus Like Particles Price by Company in 2018
Figure Global Virus Like Particles Gross Margin by Company in 2018